Chemical compound
 ;templatestyles src="Infobox drug/styles.css"/ ;
Opaganib (ABC294640) is a drug which acts as an inhibitor of the enzyme sphingosine kinase 2, dihydroceramide desaturase (DES1), and glucosylceramide synthase (GCS). It is under development as a potential treatment agent for several different kinds of cancer. Opaganib has also demonstrated antiviral activity against SARS-CoV-2 and has shown a reduction in mortality among patients with moderately severe COVID-19 in a multinational Phase 2/3 clinical trial and also appeared to exhibiting anti-inflammatory effects by reducing levels of IL-6 and TNF-alpha.
References.
 ;templatestyles src="Reflist/styles.css" / ;